Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neisseria meningitidis is a Gram-negative bacterium that causes invasive diseases such as meningitis and septicemia. Its primary virulence factor is the polysaccharide capsule that surrounds the bacterial cell. The structure of this capsule determines the serogroup classification of N. meningitidis; there are 13 described serogroups, but serogroups A, C, W (formerly W-135), and Y are among those most commonly associated with human disease. Each serogroup's capsular polysaccharide has a distinct chemical composition: Serogroup A: Capsule composed of repeating units of O-acetylated (α1→6)-linked N-acetyl-D-mannosamine-1-phosphate. Serogroup C: Capsule made up of sialic acid homopolymers with (2→9) linkages. Serogroup W: Capsule consists of alternating units of D-galactose and sialic acid. Serogroup Y: Capsule contains alternating units of D-glucose and sialic acid. These structural differences form the basis for immunological distinction between serogroups.
Induction of protective antibody responses
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisseria meningitidis Capsular Polysaccharides (Serogroups A, C, W, Y).